Online Drugs - CanMedGLobal Patient Service Menu
Currency:
No Membership Fees
We Ship Internationally
Save 50 to 90% off your local pharmacy
 DRUG FINDER: Search for Online Products   HOME    |   HOW TO ORDER    |    ABOUT US    |    FAQ    |    CANMEDGLOBAL ADVANTAGES      1-888-505-3784
News by Category:
All categories

Allergy News
Alzheimer
Anxiety / Stress News
Back Pain News
Blood / Hematology News
Breast Cancer News
Cancer / Oncology News
Cardiovascular / Cardiology News
Cholesterol News
Diabetes News
Eczema / Psoriasis News
Erectile Dysfunction
Flu / Cold / SARS News
GastroIntestinal / Gastroenterology News
Headache / Migraine News
Heart Disease
HIV / AIDS News
Hypertension News
Immune System / Vaccines News
Infectious Diseases / Bacteria / Viruses News
Parkinson's Disease News
Sleep / Sleep Disorders / Insomnia News

News by Topic:
Dermatology News
Fertility news
Nutrition / Diet News
Obesity / Weight Loss / Fitness News
Respiratory / Asthma News
Smoking / Quit Smoking News
Sexual Health / STDs News
Tropical Diseases News

News by Industry:
Complementary Medicine
Compliance News
Health Insurance / Medical Insurance News
Medicare / Medicaid / SCHIP News
Pediatrics / Children's Health News
Pharmacy / Pharmacist News
Public Health News
Seniors / Aging News
Veterinary News
headache-migraine


9/9/2010 MAP Pharmaceuticals Announces All Non-Asthmatic Patients Complete Treatment In Open-Label Trial And Completion Of Treatment In QT Trial For LEVADEXtm
MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) announced that all non-asthmatic patients and a subset of asthmatic patients have completed 12 months of treatment in the open-label safety trial of LEVADEX™. In addition, the Company has completed patient treatment in a thorough QT trial, the last trial necessary to support a New Drug Application (NDA) for LEVADEX...


9/9/2010 Head Start For Migraine Sufferers
Psychological migraine treatment gives sufferers a confidence boost in their ability to self-manage their symptoms. For severe migraine sufferers, psychological treatments build on the benefits of drug therapy, according to a new study by Elizabeth Seng and Dr. Kenneth Holroyd from Ohio University in the US...


9/9/2010 Botox Maker Allergan Agrees To Pay $600 Million And Pleads Guilty To Misdemeanor
Allergan Inc., the makers of BOTOX (onabotulinumtoxinA) announced that it has agreed to pay US $600 million and to plead guilty to misdemeanor, thus reaching a resolution with the DOJ (US Department of Justice) regarding a previously reported Government investigation into the company's past sales and marketing practices related to specific therapeutic uses of BOTOX...


9/9/2010 Genetic Link To Migraine Found, In DNA Variant On Chromosome 8
Scientists have identified the first genetic risk factor linked to a common type of migraine after examining the genetic data of over 50,000 individuals. The investigators say that this breakthrough gives them new insights into migraine triggers, which will hopefully lead to novel therapies to prevent episodes of migraine...


9/9/2010 Recurrent Teen Headaches Linked To Smoking, Overweight And Physical Inactivity
Teenagers who regularly have headaches may find that their problem is linked to overweight, smoking and/or lack of physical exercise, according to an article published in the medical journal Neurology. The authors found that teenagers with all three factors - those who were overweight, smoked and did very little exercise - were 3...


9/9/2010 Headaches In Teens Tied To Overweight, Smoking And Lack Of Exercise
Teens who are overweight, get little exercise or who smoke may be more likely to have frequent headaches and migraines than teens with none of these factors, according to a study published in the August 18, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology. Teens with all three of the negative lifestyle factors were 3...


9/9/2010 Nautilus Neurosciences Announces U.S. Launch Of CAMBIA(TM) (Diclofenac Potassium For Oral Solution) For The Treatment Of Migraine
Nautilus Neurosciences, Inc., a neurology-focused specialty pharmaceutical company headquartered in New Jersey, announced that CAMBIA(TM) (diclofenac potassium for oral solution) is now available in the United States for the acute treatment of migraine with or without aura. CAMBIA was approved by the U.S. Food and Drug Administration in June 2009...


9/9/2010 BOTOX(R) Receives First Authorisation In UK As Preventative Treatment In Chronic Migraine
Allergan has today announced that BOTOX® (botulinum toxin type A) has been licensed by the MHRA in the UK for the prophylaxis of headaches in adults who have chronic migraine (headaches on at least 15 days per month of which at least 8 days are with migraine)1...


9/9/2010 HeadCoolieTM Adjustable, Reusable Head Wrap Provides Non-Chemical, Non-Prescription Therapeutic Relief For Fever Symptoms And Headaches
American Diversified Medical Corporation, a majority owned subsidiary of ThermaFreeze Products Corporation (PINKSHEETS: TZPC), unveiled its newest product line, the HeadCoolie™...


9/9/2010 A Simple Massage Is Proven To Relieve Psychological And Physiological State Of Patients With Chronic Tension Headache
Researchers at the University of Granada -in collaboration with the Clinical Hospital San Cecilio and the University Rey Juan Carlos- have proven that the psychological and physiological state of patients with tension headache improves within 24 hours after receiving a 30-minute massage. As researchers explained, tension headaches have an increasing incidence in the population...


9/9/2010 GlaxoSmithKline And XenoPort Report Top-Line Phase 2b Results For GSK1838262/XP13512 As A Prophylactic Treatment For Migraine Headache
GlaxoSmithKline (NYSE:GSK) and XenoPort, Inc. (Nasdaq:XNPT) announced today that GSK1838262/XP13512 (gabapentin enacarbil) did not demonstrate a statistically significant improvement compared to placebo as a prophylactic treatment for migraine headaches...


9/9/2010 REM Sleep Deprivation Plays A Role In Chronic Migraine
Reporting at the American Headache Society's 52nd Annual Scientific Meeting in Los Angeles this week, new research shows that sleep deprivation leads to changes in the levels of key proteins that facilitate events involved in the underlying pathology of migraine. Paul L. Dunham, Ph.D...


9/9/2010 Migraine: Abnormal Brain Activity Not Restricted To Attacks
Typically, migraine is considered to be an episodic disorder with discrete attacks of headache. But new research by Dr. Till Sprenger and his team from UCSF Headache Group and Technische Universitat Munchen found increased network activity -- stronger functional connectivity -- bilaterally in the visual, auditory and sensorimotor network in migraineurs...


9/9/2010 Soldiers With Migraine Endure Poor Sleep Quality
Some 19 percent of soldiers returning from Iraq have migraine and migraine is suspected in another 17 percent. While prevalence of migraine among the U.S. military is well documented , little is known about sleep quality in soldiers with chronic headaches including post-traumatic headache and migraine...


9/9/2010 Migraine Sufferers Who Experienced Childhood Abuse Have Greater Risk Of Cardiovascular Disease
Migraine sufferers who experienced abuse and neglect as children have a greater risk of cardiovascular (CV) disease including stroke and myocardial infarction (MI) among others, say scientists presenting data at the American Headache Society's 52nd Annual Scientific Meeting in Los Angeles this week...


9/9/2010 Stigma Of Migraine Is Significant; Worse For Those With Chronic Migraine
Researchers looking for the first time at how migraine sufferers experience the stigmatizing effects of their disease show that chronic migraine sufferers experience worse stigma than episodic migraine sufferers and more than those with other neurological diseases including stroke, epilepsy and MS...


9/9/2010 Link Between Adverse Childhood Experiences And Frequent Headache In Adults
Children who experience maltreatment such as emotional, physical and sexual abuse are more likely to experience frequent headaches, including chronic migraine, as adults, say scientists presenting data at the American Headache Society's 52nd Annual Scientific Meeting in Los Angeles this week...


9/9/2010 Oral Efficacy Of Lasmiditan (COL-144), A Selective 5-HT1F Receptor Agonist, In The Treatment Of Acute Migraine Attacks - Study Data
CoLucid Pharmaceuticals, Inc...


9/9/2010 Sitting In Front Of A Screen Associated With Physical Complaints In Teenagers
The amount of time teenagers spend in front of TV screens and monitors has been associated with physical complaints. A large study of more than 30,000 Nordic teenagers published in the open access journal BMC Public Health has shown that TV viewing, computer use and computer gaming (screen time) were consistently associated with back pain and recurrent headaches...


9/9/2010 Treatment For Headaches And Dizziness Caused By Traumatic Brain Injury Appears Promising, Study Says
A recent retrospective study by four Michigan physicians shows strong evidence that symptoms of headache, dizziness and anxiety in some patients with traumatic brain injury potentially could be alleviated or even eliminated with specialized eyeglass lenses containing prisms. The paper was published in the April 2010 issue of Physical Medicine and Rehabilitation...


9/9/2010 Modifiable Risk Factors For Headaches And Migraines In Teens
A novel study by German researchers reported that alcohol consumption and cigarette smoking were associated with increased migraines and tension-type headaches (TTH) in high school students. Coffee drinking and physical inactivity were associated specifically with migraines...


9/9/2010 Trigemina, Inc. Reports Preliminary Results For Phase IIa Clinical Trial In Chronic Daily Headache
Trigemina, Inc. (TI), a Mountain View based privately-held biopharmaceutical company, reports positive results from a time-based interim analysis of its Phase IIa clinical trial in Chronic Daily Headache (CDH). The trial is a collaborative effort between Trigemina and Dr. Egilius Spierings of MedVadis Research Corporation located outside of Boston...


9/9/2010 In The Dentist's Chair A Sniff Of Local Anesthetic Could Replace The Needle
Modern dentistry has eliminated much of the "ouch!" from getting a shot of local anesthetic. Now a new discovery may replace the needle used to give local anesthetic in the dentist's chair for many procedures...


9/9/2010 Ortho-McNeil-Janssen Pharmaceuticals, Inc. Resolves Investigation Of Past TOPAMAX(R) Marketing And Promotional Activities
Ortho-McNeil-Janssen Pharmaceuticals, Inc. (OMJPI) announced an agreement with the U.S. Attorney's Office for the District of Massachusetts, the U.S. Department of Justice, and other federal agencies to resolve a previously reported government investigation of past U.S...


9/9/2010 MAP Pharmaceuticals Announces Potential Of LEVADEX(TM) To Treat Patients With Menstrual Migraine And With Allodynia During Migraine
MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) announced additional post-hoc analyses of data from the FREEDOM-301 Phase 3 trial of its investigational LEVADEX™ orally inhaled migraine therapy showing efficacy in two difficult to treat patient subpopulations, menstrual migraine and migraine with allodynia...

CanMedGlobal.com advantages
CanMedGlobal.com advantages

Save 50 to 90% off your local pharmacy
No Membership Fees No Membership Fees
We Ship Internationally We Ship Internationally
Fast Service, Fast delivery time Fast Service, Fast delivery time

secure transaction
Secure Purchase

Secure SSL Encryption and Secure Checkout
Fast Service, Fast delivery time Privacy - Confidentiality

CanMedGlobal.com - Online Drug help
Help

How to Order your prescription
Online Drugs My Account
Online Drugs Create a new account
Online Drugs Download Order form
Online Drugs Track my order
Online Drugs Reorder my prescriptions


Home page
About CanMedGlobal
Our mission
Medical News Today
Contact us

How to Order your prescription

My Account
Create a new account
Download Order form
Track my order
Reorder my prescriptions

FAQ
Sales & Order conditions
Privacy
Shipping
Returns

Copyright CanMedGlobal © 2009

VISA Credit Card Bookmark and Share

McAfee Secure sites help keep you safe from identity theft, credit card fraud, spyware, spam, viruses and online scams
 
"Please be sure to verify the importation regulations for the country in which you reside. U.S. residents note: The FDA, due to the current state of their regulations, has taken the position that virtually all shipments of prescription drugs imported from a Canadian pharmacy by a U.S. consumer will violate the law.

Prices as of Thursday, September 09, 2010 Subject to change. Some meds are not suitable for international delivery. By prescription only (RX) Return Policy: Due to the nature of the Products, Products are not returnable. All sales are final sales."
Resources | Add URL | Related Sites | SpyderMap | Web PortalRelated Articles